Fainardi, Enrico <br/><br/>
Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy.  [electronic resource] 

 -  Journal of neuroimmunology  Mar 2004 
 - 206-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0165-5728 
<br/><br/><label>Standard No.: </label>10.1016/j.jneuroim.2003.12.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Disability Evaluation<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Female<br/>HLA Antigens--blood<br/>Humans<br/>Interferon beta-1b<br/>Interferon-beta--therapeutic use<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--blood<br/>Statistics, Nonparametric<br/>Time Factors